Myriad
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Myriad Genetics Q3 Revenues Increase 15 Percent
The company reported $167.3 million in revenues compared to $145.2 million last year, beating the consensus Wall Street estimate.
In Brief This Week: Roche, Myriad Genetics, Danaher, and More
News items for the in vitro diagnostics industry for the week of Sept. 13, 2021.
Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay
Under the terms of the deal, Illumina will develop a new HRD CDx for the EU and UK markets and a research-use only HRD assay that will be add-on content for its TSO 500 panel.
360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August
Of the 29 companies in the index, 18 saw increases in their stock prices, while 11 saw declines.